HALDOL Side Effects

7023628-1 | Electrocardiogram Qt Prolonged
on Sep 30, 2010 Female patient from UNITED STATES , weighting 192.5 lb, was diagnosed with agitation, depression (What is depression?) and was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged. Haldol dosage: 5 Mg And 0.5 Mg Q 4 Hours Prn Oral/im, 8/27-9/1. During the same period patient was treated with LEXAPRO (20 Mg Daily Oral, 8/26 - 8/31) (View Lexapro Review and Lexapro Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), MACRODANTIN (View Macrodantin Review and Macrodantin Label ), GEODON (View Geodon Review and Geodon Label ), THORAZINE (View Thorazine Review and Thorazine Label ), ABILIFY (View Abilify Review and Abilify Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

7020024-8 | Asthenia, Muscle Rigidity
Patient was taking Haldol (View Usage). Patient had the following side effects: asthenia, muscle rigidity on Sep 21, 2010 from BRAZIL Additional patient health information: Female patient , 55 years of age, weighting 132.3 lb, was diagnosed with nervousness and. Haldol dosage: .

7015543-4 |
Adverse event was reported on Sep 16, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 130.0 lb, . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

7012419-3 | Amnesia
on Sep 17, 2010 Female patient from BRAZIL , 50 years of age, was diagnosed with hallucination and was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia. Haldol dosage: .


7006992-9 |
on Sep 16, 2010 Male patient from UNITED STATES , weighting 130.0 lb, was treated with Haldol (View Usage). . Haldol dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

7005338-X | Self Injurious Behaviour
Patient was taking Haldol (View Usage). After Haldol was administered, patient had the following side effects: self injurious behaviour on Sep 13, 2010 from ITALY Additional patient health information: Female patient , 45 years of age, was diagnosed with self injurious behaviour and. Haldol dosage: .

6994508-2 | Self Injurious Behaviour
Adverse event was reported on Sep 08, 2010 by a Female patient taking Haldol (View Usage) (Dosage: ) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: ITALY , 38 years of age, Patient experienced the following unwanted or unexpected effects: self injurious behaviour. Patient was hospitalized.

6994459-3 | Pancytopenia, Psychotic Disorder, Purpura
on Sep 07, 2010 Male patient from FRANCE , 56 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Haldol (View Usage). Patient had the following side effects: pancytopenia, psychotic disorder (What is psychotic disorder?), purpura. Haldol dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), LOXAPINE (View Loxapine Review and Loxapine Label ), AMISULPRIDE (View Amisulpride Review and Amisulpride Label ), TROPATEPINE (View Tropatepine Review and Tropatepine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), CLORAZEPATE DIPOTASSIUM (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ). Patient was hospitalized.

6987126-3 | Cardiac Arrest, Mental Status Changes, Myocardial Infarction, Pulmonary Embolism, Pulmonary Haemorrhage, Pulmonary Oedema, Thrombosis
on Sep 10, 2010 Male patient from UNITED STATES , weighting 135.0 lb, was diagnosed with schizophrenia, delirium, agitation, thrombosis, atrial fibrillation (What is atrial fibrillation?) and was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), mental status changes, myocardial infarction, pulmonary embolism (What is pulmonary embolism?), pulmonary haemorrhage, pulmonary oedema, thrombosis. Haldol dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6973363-0 | Intentional Overdose, Self Injurious Behaviour
Patient was taking Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose, self injurious behaviour on Sep 03, 2010 from ITALY Additional patient health information: Male patient , 34 years of age, weighting 132.3 lb, . Haldol dosage: .

6972352-X | Chills, Dizziness, Gait Disturbance, Transient Ischaemic Attack, Tremor
Adverse event was reported on Sep 01, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) was diagnosed with schizophrenia, paranoid type and. Location: SWITZERLAND , 66 years of age, Patient had the following side effects: chills, dizziness (What is dizziness?), gait disturbance, transient ischaemic attack, tremor.

6968557-4 | Dyskinesia, Dystonia, Self Injurious Behaviour
on Aug 29, 2010 Male patient from ITALY , 35 years of age, was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: dyskinesia, dystonia (What is dystonia?), self injurious behaviour. Haldol dosage: . During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6962388-7 | Self Injurious Behaviour
on Aug 24, 2010 Male patient from ITALY , 27 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: self injurious behaviour. Haldol dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), AKINETON (View Akineton Review and Akineton Label ).

6958566-3 | Extrapyramidal Disorder
Patient was taking Haldol (View Usage). Patient had the following side effects: extrapyramidal disorder on Aug 30, 2010 from UNITED STATES Additional patient health information: Male patient , 20 years of age, weighting 185.0 lb, was diagnosed with major depression and. Haldol dosage: 10mg Bid Po.

6945367-5 | Sopor
Adverse event was reported on Aug 19, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: ITALY , 37 years of age, After Haldol was administered, patient had the following side effects: sopor. During the same period patient was treated with TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ).

6935682-3 | Dysarthria, Self Injurious Behaviour, Sluggishness
on Aug 14, 2010 Male patient from ITALY , 26 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria, self injurious behaviour, sluggishness. Haldol dosage: .

6933630-3 | Bradycardia, Sluggishness
on Aug 12, 2010 Female patient from ITALY , 59 years of age, was treated with Haldol (View Usage). Patient had the following side effects: bradycardia, sluggishness. Haldol dosage: 30-40 Gtt. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), XANAX (View Xanax Review and Xanax Label ).

6924933-7 | Self Injurious Behaviour, Sopor
Patient was taking Haldol (View Usage). After Haldol was administered, patient had the following side effects: self injurious behaviour, sopor on Aug 08, 2010 from ITALY Additional patient health information: Female patient , 39 years of age, was diagnosed with self injurious behaviour and. Haldol dosage: 30 Tablets Of 5mg Haloperidol. During the same period patient was treated with TIROSINT (75 Tablets Of Of Levothyroxine Sodium (100ug)) (View Tirosint Review and Tirosint Label ).

6924932-5 | Neuroleptic Malignant Syndrome, Psychotic Disorder, Treatment Noncompliance
Adverse event was reported on Aug 06, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) was diagnosed with schizophrenia, paranoid type and. Location: SWITZERLAND , 25 years of age, Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome, psychotic disorder (What is psychotic disorder?), treatment noncompliance. During the same period patient was treated with RISPERDAL CONSTA (View Risperdal Consta Review and Risperdal Consta Label ), NOZINAN (View Nozinan Review and Nozinan Label ). Patient was hospitalized.

6924165-2 | Abasia, Aphasia, Haematemesis, Parkinson's Disease, Tremor
on Aug 12, 2010 Female patient from UNITED STATES , weighting 170.0 lb, was treated with Haldol (View Usage). Patient had the following side effects: abasia, aphasia (What is aphasia?), haematemesis, parkinson's disease (What is parkinson's disease?), tremor. Haldol dosage: Shots Monthly. During the same period patient was treated with RISPERDAL (Shots Monthly) (View Risperdal Review and Risperdal Label ).

6923202-9 | Bone Marrow Failure
on Aug 02, 2010 Male patient from BRAZIL , 78 years of age, weighting 172.0 lb, was diagnosed with dementia (What is dementia?), abnormal behaviour, diabetes mellitus and was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: bone marrow failure. Haldol dosage: 8 Drops At Night. During the same period patient was treated with MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), EXELON (Dose Of 4.5) (View Exelon Review and Exelon Label ), AKINETON (View Akineton Review and Akineton Label ), OLANZAPINE (2.5) (View Olanzapine Review and Olanzapine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6922400-8 | Bone Marrow Failure
Patient was taking Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure on Aug 06, 2010 from BRAZIL Additional patient health information: Male patient , 78 years of age, weighting 172.0 lb, was diagnosed with dementia (What is dementia?), abnormal behaviour, diabetes mellitus and. Haldol dosage: 8 Drops At Night. During the same period patient was treated with MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), EXELON (Dose Of 4.5) (View Exelon Review and Exelon Label ), AKINETON (View Akineton Review and Akineton Label ), OLANZAPINE (2.5) (View Olanzapine Review and Olanzapine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6918557-5 | Dyspnoea, Muscle Spasms
Adverse event was reported on Aug 03, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) was diagnosed with anxiety (What is anxiety?) and. Location: UNITED STATES , weighting 189.0 lb, Patient had the following side effects: dyspnoea, muscle spasms. Patient was hospitalized.

6913736-5 | Disability
on Aug 06, 2010 Male patient from UNITED STATES , 86 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: disability. Haldol dosage: Hospital Would Not Provide Info. Patient was hospitalized and became disabled.

6911363-7 | Intentional Self-injury, Suicidal Ideation
on Jul 29, 2010 Female patient from UNITED STATES , 77 years of age, was diagnosed with schizophrenia and was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: intentional self-injury, suicidal ideation. Haldol dosage: . During the same period patient was treated with ASENAPINE (View Asenapine Review and Asenapine Label ), IMIPRAMINE (View Imipramine Review and Imipramine Label ), ATIVAN (View Ativan Review and Ativan Label ).

6909128-5 | Gait Disturbance, Oedema Peripheral, Vasculitis
Patient was taking Haldol (View Usage). Patient had the following side effects: gait disturbance, oedema peripheral, vasculitis (What is vasculitis?) on Jul 28, 2010 from BRAZIL Additional patient health information: Female patient , 77 years of age, weighting 114.6 lb, was diagnosed with dyskinesia and. Haldol dosage: 3 Doses. Patient was hospitalized.

6894133-8 | Bone Marrow Failure
Adverse event was reported on Jul 26, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) was diagnosed with dementia (What is dementia?) and. Location: BRAZIL , 78 years of age, After Haldol was administered, patient had the following side effects: bone marrow failure. During the same period patient was treated with MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), EXELON (View Exelon Review and Exelon Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ). Patient was hospitalized.

6894131-4 | Blood Cholesterol Increased, Hepatic Enzyme Increased, Oedema Peripheral
on Jul 26, 2010 Female patient from GERMANY , 58 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, hepatic enzyme increased, oedema peripheral. Haldol dosage: . During the same period patient was treated with VALDOXAN (AGOMELATINE) (View Valdoxan (agomelatine) Review and Valdoxan (agomelatine) Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), MAGNESIUM VERLA (View Magnesium Verla Review and Magnesium Verla Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6894130-2 | Hypertonia, Sinus Arrhythmia, Tremor
on Jul 22, 2010 Male patient from FRANCE , weighting 40.79 lb, was treated with Haldol (View Usage). Patient had the following side effects: hypertonia, sinus arrhythmia, tremor. Haldol dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6887794-0 | Acute Pulmonary Oedema, Aphasia, Cardiac Failure Congestive, Dehydration, Depressed Level Of Consciousness, Diabetic Coma, Dyskinesia, Muscle Rigidity, Parkinsonism
Patient was taking Haldol (View Usage). After Haldol was administered, patient had the following side effects: acute pulmonary oedema, aphasia (What is aphasia?), cardiac failure congestive, dehydration, depressed level of consciousness, diabetic coma, dyskinesia, muscle rigidity, parkinsonism on Jul 26, 2010 from BRAZIL Additional patient health information: Female patient , 89 years of age, was diagnosed with dementia (What is dementia?) and. Haldol dosage: 8 Drops Per Day. During the same period patient was treated with MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), EXELON (View Exelon Review and Exelon Label ), CLOPIXOL (View Clopixol Review and Clopixol Label ). Patient was hospitalized.

6887076-7 | Intentional Overdose, Self Injurious Behaviour
Adverse event was reported on Jul 22, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: ITALY , 52 years of age, Patient experienced the following unwanted or unexpected effects: intentional overdose, self injurious behaviour.

6883106-7 | Self Injurious Behaviour, Sopor
on Jul 22, 2010 Female patient from ITALY , 55 years of age, was treated with Haldol (View Usage). Patient had the following side effects: self injurious behaviour, sopor. Haldol dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SEROQUEL (8 Tablets) (View Seroquel Review and Seroquel Label ).

6883101-8 | Self Injurious Behaviour, Vertigo
on Jul 21, 2010 Male patient from ITALY , 47 years of age, was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: self injurious behaviour, vertigo. Haldol dosage: .

6875520-0 | Self Injurious Behaviour
Patient was taking Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: self injurious behaviour on Jul 17, 2010 from ITALY Additional patient health information: Female patient , 38 years of age, . Haldol dosage: .

6866141-4 | Self Injurious Behaviour
Adverse event was reported on Jul 15, 2010 by a Female patient taking Haldol (View Usage) (Dosage: ) . Location: ITALY , 50 years of age, Patient had the following side effects: self injurious behaviour. During the same period patient was treated with OKI (View Oki Review and Oki Label ).

6848489-2 | Self Injurious Behaviour
on Jul 09, 2010 Female patient from ITALY , 40 years of age, was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: self injurious behaviour. Haldol dosage: . During the same period patient was treated with TALOFEN (View Talofen Review and Talofen Label ), GUTRON (View Gutron Review and Gutron Label ), SEROQUEL (View Seroquel Review and Seroquel Label ).

6848488-0 | Self Injurious Behaviour
on Jul 08, 2010 Female patient from ITALY , 28 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: self injurious behaviour. Haldol dosage: . During the same period patient was treated with AKINETON (View Akineton Review and Akineton Label ).

6848487-9 | Abdominal Distension, Aggression, Apathy, Breast Enlargement, Dry Mouth, Injection Site Nodule, Insomnia, Malaise, Muscle Spasms
Patient was taking Haldol (View Usage). Patient had the following side effects: abdominal distension, aggression, apathy, breast enlargement, dry mouth, injection site nodule, insomnia, malaise, muscle spasms on Jul 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 44 years of age, . Haldol dosage: .

6839984-0 | Erythema, Fluid Retention, Hyperhidrosis, Musculoskeletal Stiffness, Nasal Congestion, Oedema, Paraesthesia, Photosensitivity Reaction, Poor Peripheral Circulation
Adverse event was reported on Jul 06, 2010 by a Female patient taking Haldol (View Usage) (Dosage: ) was diagnosed with hallucination and. Location: SWEDEN , 62 years of age, weighting 240.3 lb, After Haldol was administered, patient had the following side effects: erythema, fluid retention, hyperhidrosis, musculoskeletal stiffness, nasal congestion, oedema, paraesthesia, photosensitivity reaction, poor peripheral circulation.

6835316-2 | Self Injurious Behaviour, Sluggishness
on Jul 04, 2010 Male patient from ITALY , 47 years of age, was diagnosed with self injurious behaviour and was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: self injurious behaviour, sluggishness. Haldol dosage: . During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6822140-X | Aggression, Haemorrhoids, Homicide, Impulse-control Disorder
on Jun 29, 2010 Male patient from NETHERLANDS , weighting 165.3 lb, was diagnosed with delusion, major depression, somnolence and was treated with Haldol (View Usage). Patient had the following side effects: aggression, haemorrhoids, homicide, impulse-control disorder. Haldol dosage: . During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ).

6814525-2 | Sopor
Patient was taking Haldol (View Usage). After Haldol was administered, patient had the following side effects: sopor on Jun 24, 2010 from ITALY Additional patient health information: Male patient , 46 years of age, . Haldol dosage: . During the same period patient was treated with ASACOLON (View Asacolon Review and Asacolon Label ).

6803583-7 | Intentional Overdose, Self Injurious Behaviour
Adverse event was reported on Jun 21, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: ITALY , 42 years of age, Patient experienced the following unwanted or unexpected effects: intentional overdose, self injurious behaviour.

6803582-5 | Self Injurious Behaviour
on Jun 20, 2010 Female patient from ITALY , 32 years of age, was treated with Haldol (View Usage). Patient had the following side effects: self injurious behaviour. Haldol dosage: . During the same period patient was treated with VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ), XERISTAR (View Xeristar Review and Xeristar Label ), MODALINA (8 Tablets) (View Modalina Review and Modalina Label ).

6796091-3 | Aphasia, Asthenia, Dysphemia, Gait Disturbance, Miosis, Salivary Hypersecretion, Sedation, Vomiting
on Jun 18, 2010 Male patient from GERMANY , 30 years of age, weighting 146.6 lb, was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: aphasia (What is aphasia?), asthenia, dysphemia, gait disturbance, miosis, salivary hypersecretion, sedation, vomiting. Haldol dosage: . During the same period patient was treated with LEVOMEPROMAZIN (View Levomepromazin Review and Levomepromazin Label ). Patient was hospitalized.

6794638-4 | Dyspnoea, Muscle Spasms
Patient was taking Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, muscle spasms on Jun 18, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 189.0 lb, was diagnosed with anxiety (What is anxiety?) and. Haldol dosage: . Patient was hospitalized.

6794637-2 | Agranulocytosis, Dyspnoea, Psychomotor Skills Impaired, Sluggishness, Stress, Weight Increased
Adverse event was reported on Jun 18, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: GERMANY , 54 years of age, weighting 194.0 lb, Patient had the following side effects: agranulocytosis, dyspnoea, psychomotor skills impaired, sluggishness, stress (What is stress?), weight increased. During the same period patient was treated with LEPONEX (View Leponex Review and Leponex Label ). Patient was hospitalized.

6790922-9 | Self Injurious Behaviour
on Jun 17, 2010 Male patient from ITALY , 21 years of age, was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: self injurious behaviour. Haldol dosage: . During the same period patient was treated with SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).

6785578-5 | Hepatic Enzyme Increased, Oedema Peripheral
on Jun 14, 2010 Female patient from GERMANY , 58 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, oedema peripheral. Haldol dosage: . During the same period patient was treated with VALDOXAN (AGOMELATINE) (View Valdoxan (agomelatine) Review and Valdoxan (agomelatine) Label ), SIFROL (View Sifrol Review and Sifrol Label ), MAGNESIUM VERLA (View Magnesium Verla Review and Magnesium Verla Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6783187-5 | Aphasia, Asthenia, Dysphemia, Gait Disturbance, Miosis, Salivary Hypersecretion, Sedation, Vomiting
Patient was taking Haldol (View Usage). Patient had the following side effects: aphasia (What is aphasia?), asthenia, dysphemia, gait disturbance, miosis, salivary hypersecretion, sedation, vomiting on Jun 14, 2010 from GERMANY Additional patient health information: Male patient , 30 years of age, weighting 146.6 lb, . Haldol dosage: . During the same period patient was treated with LEVOMEPROMAZIN (View Levomepromazin Review and Levomepromazin Label ). Patient was hospitalized.